Optherion Pharmaceutical Presentations at ARVO 2009
April 30, 2009
Submit Comments
Optherion, Inc., a company developing novel molecular diagnostics and treatments for dry and wet Age-related Macular Degeneration (AMD) and other chronic diseases involving the alternative complement system, announced that it will be reporting data from its diagnostics development program at ARVO 2009.
The title of the poster presentation is “A Clinical Study to Identify a Population with Blood-Based Biomarkers for Age-Related Macular Degeneration (AMD).”
Read the full release.
Comments (0)
Trackbacks
Print this post
Filed in Macular Degeneration, Meetings, Organizations, Research, Retina
You might also enjoy...
- pSivida Corp Presentations at ARVO 2009
- Sirion Therapeutics Presentation at ARVO 2009
- Quick Updates from ARVO 2011
- TransMolecular, Inc. Presentation at ARVO 2009
- ARVO 2009 Meta Analysis of Diabetic Retinopathy
Comments
Jump down to form below to submit your own comments
